Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 8:26:16046.
doi: 10.1038/npjpcrm.2016.46.

Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study

Affiliations

Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study

Miguel Santibañez Margüello et al. NPJ Prim Care Respir Med. .

Abstract

Few studies have researched the independent effect of COPD severity on the risk of future exacerbations adjusted by previous exacerbation frequency. We aimed to analyse the independent effect of COPD severity on the risk of exacerbations in the following year, and whether this effect was stronger or not than the effect of a previous history of exacerbations. We conducted a retrospective population-based cohort study including 900 patients with confirmed COPD. Exacerbation frequency was observed for the previous year and for the following year. Patients were defined as 'Frequent Exacerbator' (FE) phenotype if they suffered ⩾2 exacerbations in a year, and were categorised according to the severity of COPD (GOLD Grades 1-4). Odds ratios (ORs) were estimated by logistic regression adjusting for age, gender, smoking status, severity of COPD and being FE in the previous year. The main predictor of being FE among all grades of COPD severity was a history of frequent exacerbations in the previous year: adjusted OR 4.97; 95% confidence interval (CI) (3.54-6.97). COPD severity was associated with a higher risk of being FE: Crude OR GOLD Grade 4 3.86; 95% CI (1.50-9.93). However, this association diminished after adjusting for being FE in the previous year: adjusted OR 2.08; 95% CI (0.75-5.82). Our results support that a history of frequent exacerbations in the previous year is the most important independent predictor of exacerbations in the following year, also among the most severe COPD patients. Severity of COPD would be associated with a higher risk of exacerbations, but this effect would be partly determined by the exacerbations suffered in the previous year.

PubMed Disclaimer

Conflict of interest statement

J.L.G-R. reports receiving consulting and/or speaking fees from Almirall, Boehringer Ingelheim, Pfizer, Astra Zeneca, Chiesi, GlaxoSmithKline, Menarini, Takeda, Teva and Ferrer y Novartis; J.M.H. reports receiving speaking fees from GlaxoSmithKline, Boehringer, Novartis, Mundipharma and y Astra Zeneca; C.B. reports receiving speaking fees from GlaxoSmithKline, Boehringer, Ferrer, Astra Zeneca and Teva, y Chiesi; M.M. reports receiving consulting and/or speaking fees from Almirall, AstraZeneca, Boehringer Ingelheim, Ferrer Group, GlaxoSmithKline, Grifols, Esteve, Pfizer, Teva, Cipla, Novartis and Gebro Pharma y Takeda. The remaning authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart for selection of the study sample.

Similar articles

Cited by

References

    1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012). - PMC - PubMed
    1. Zhou, Y. et al. COPD in Chinese nonsmokers. Eur. Respir. J. 33, 509–518 (2009). - PubMed
    1. Shirtcliffe, P. et al. COPD prevalence in a random population survey: a matter of definition. Eur. Respir. J. 30, 232–239 (2007). - PMC - PubMed
    1. Menezes, A. M. et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366, 1875–1881 (2005). - PubMed
    1. Wedzicha, J. A., Brill, S. E., Allinson, J. P. & Donaldson, G. C. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 11, 181 (2013). - PMC - PubMed